title: Cidofovir may be deleterious in BK virus-associated nephropathy.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Pallet
authors.forename: Marianne
authors.initials: M
authors.lastname: Burgard
authors.forename: Ouadie
authors.initials: O
authors.lastname: Quamouss
authors.forename: Marion
authors.initials: M
authors.lastname: Rabant
authors.forename: Lynda
authors.initials: L
authors.lastname: Bererhi
authors.forename: Frank
authors.initials: F
authors.lastname: Martinez
authors.forename: Eric
authors.initials: E
authors.lastname: Thervet
authors.forename: Dany
authors.initials: D
authors.lastname: Anglicheau
authors.forename: Laure-Hélène
authors.initials: LH
authors.lastname: Noel
authors.forename: Christine
authors.initials: C
authors.lastname: Rouzioux
authors.forename: Christophe
authors.initials: C
authors.lastname: Legendre
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001739:BK Virus / Q000378:metabolism*; D000077404:Cidofovir; D003596:Cytosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006085:Graft Survival; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000821:virology*; D016030:Kidney Transplantation / Q000009:adverse effects; D063065:Organophosphonates / Q000009:adverse effects*; D027601:Polyomavirus Infections / Q000188:drug therapy*; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir